CEMIP promotes gefitinib resistance in lung cancer with EGFR-mutation possibly through forming a stable complex CEMIP/c-MYC.
CEMIP 可能通过形成稳定的复合物 CEMIP/c-MYC 促进 EGFR 突变肺癌对吉非替尼的耐药性。
期刊:BBA Advances
影响因子:3
doi:10.1016/j.bbadva.2025.100176
Li Li, Xie Jiaxiu, Liang Jinxing, Su Hua, Shen Xiaoju, Mo Xiaoxiang, Lin Xinli, Tan Weidan, Wu Kun, Zhu Fucui, Wang Li, Liu Ying